Topic: Eric Campbell
U.S. physicians' links with drug makers, medical device manufacturers and other health-related companies have decreased since 2004, but many doctors still have ties to these businesses, new research shows.. Nearly two-thirds (63.8 percent) accepted drug samples, about 70 percent received ...
Fewer physicians received drug samples, food and beverages, reimbursement, or payment for professional services in 2009 than in 2004, but a large majority of physicians still report financial relationships with industry, according to research published in the Nov. 8 issue of the ...
Fewer academic biomedical scientists are relying on industry support for their research than in the mid-'90s. That's the most surprising result of the latest survey of industry relationships at universities led by conflicts-of-interest expert Eric Campbell of the Massachusetts General ...
An intoxicated coworker in many workplaces might be more of a nuisance than a threat. The American Medical Association (AMA) asserts that all doctors have an "ethical obligation to report" colleagues who are suspected of being unable to safely fulfill their duties ...
A review and analysis of previously published studies finds that patients, research participants and journal readers believe financial relationships between medicine and industry should be disclosed, in part because those financial ties may influence research and clinical care, according to a report ...
For years we've heard, and joined in on, complaints about the pharmaceutical industry and its payments to doctors. What's wrong with pharmaceutical companies paying doctors to do that type of work?. In fact, Pfizer paid (at least) $35 million to ...
Hardly isolated from commercial ties, researchers in the ivory towers-and labs-of U.S. universities receive an average of $33,417 of funding a year from medical device, pharmaceutical and other medical industry companies, according to a study published yesterday in the Journal ...
Research at academic medical centers is active and diverse, with nearly a quarter of life-science researchers receiving no funding, and relationships with industry more commonly seen among translational and clinical researchers than basic science researchers, according to a study in the Sept ...
It's noon, and strains of Pachelbel's Canon are floating down the staircase of a Pompeu Fabra University building in Barcelona, Spain. "If drugs are proved not to be effective or to have some bad effects, [there may be] pressure not ...
So says a survey of physicians' attitudes led by Eric Campbell at the Massachusetts General Hospital in Boston. His team surveyed more than 3500 US doctors, probing their attitudes to a professional charter introduced in 2002. For instance, 24 per cent of ...